Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs

Julia Kirchheiner, Ivar Roots, Mark Goldammer, Bernd Rosenkranz, J??rgen Brockm??ller
  • Clinical Pharmacokinetics, January 2005, Springer Science + Business Media
  • DOI: 10.2165/00003088-200544120-00002

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Bernd Rosenkranz